It is a chemicals private limited company based in Ulh-4, Ulhasnagar-4, Maharashtra, India, established in 2019.
2019 | Ulh-4, Ulhasnagar-4, Maharashtra, India | ActiveSealife Pharmaceuticals Private Limited, a active private limited company, was established on 27 May 2019 in Ulh-4, Ulhasnagar-4, Maharashtra, India. Engaging in fine chemicals and other chemical products within the chemicals sector, it holds CIN: U24299MH2019PTC325928. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Anish Singh (Additional Director), Swapnil Madhukar Attarde (Additional Director), Prakash Khubchand Kaurani (Director). Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Murli Manohar Apt Shop 6A-462-463/923-924-925, Ulh-4, Ulhasnagar-4, Maharashtra, 421004.
U24299MH2019PTC325928
325928
27 May 2019
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sealife Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anish Singh | Additional Director | 22 Aug 2019 | Current |
| Swapnil Madhukar Attarde | Additional Director | 22 Aug 2019 | Current |
| Prakash Khubchand Kaurani | Director | 22 Aug 2019 | Current |
| Manoj Dinesh Singh | Director | 27 May 2019 | Current |
| Ninad Rajendra Markandey | Director | 27 May 2019 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sealife Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 16.23% decrease. The company also saw a substantial improvement in profitability, with a 68.49% increase in profit. The company's net worth Soared by an impressive increase of 83.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Sealife Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sealife Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sealife Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sealife Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sealife Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
The activity Sealife Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was completed.
Progress on Anish Singh was appointed as a Additional Director was appointed as a Additional Director on 22 Aug 2019 & has been associated with this company since 6 years 3 months . was documented.
Swapnil Madhukar Attarde was appointed as a Additional Director was appointed as a Additional Director on 22 Aug 2019 & has been associated with this company since 6 years 3 months . was recorded as a recent event.
The activity Prakash Khubchand Kaurani was appointed as a Director was appointed as a Director on 22 Aug 2019 & has been associated with this company since 6 years 3 months . was completed.
Progress on Manoj Dinesh Singh was appointed as a Director was appointed as a Director on 27 May 2019 & has been associated with this company since 6 years 6 months . was documented.
The CIN of Sealife Pharmaceuticals Private Limited is U24299MH2019PTC325928.
Sealife Pharmaceuticals Private Limited is headquartered at Murli Manohar Apt Shop 6A-462-463/923-924-925, Ulh-4, Ulhasnagar-4, Maharashtra, 421004.
Sealife Pharmaceuticals Private Limited was incorporated on 27 May 2019.
The current directors of Sealife Pharmaceuticals Private Limited are
The primary industry of Sealife Pharmaceuticals Private Limited is Chemicals.
Sealife Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sealife Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX